We have explored the eects of the conditional MYCestrogen receptor fusion protein, MYC-ER TM , in human mortal ®broblasts, WI38, on cell-cycle entry, apoptosis and gene expression. The results indicate that activation of MYC-ER TM in WI38 cells is sucient to cause S phase entry of quiescent cells, which is preceded by phosphorylation of Rb and activation of the Cdk2-associated kinase. We also analysed the MYC protein variant, MYC-S, which lacks part of the transcriptional activation domain but includes the conserved MYC box II and 26 amino acids N-terminal to it. MYC-S was previously shown to promote proliferation and apoptosis of immortalized rodent cell lines. The results indicate that MYC-S has undetectable activity as an inducer of S phase or apoptosis of quiescent WI38 cells. However, Myc-S stimulates proliferation of WI38 cells in the presence of 10% fetal calf serum. Surprisingly, we found that MYC-S, previously considered solely a repressor of speci®c reporter genes, is instead a weak transactivator of endogenous target genes both in mortal and immortalized cells. In addition, MYC-S exhibit a weak repressor activity upon an endogenous target gene only in immortalized cells. MYC-S transcriptional properties suggest that MYC box II and the adjacent N-terminal amino acids, while not sucient for full repression function, participate in transactivation of endogenous target genes. Oncogene (2000) 19, 5189 ± 5197.
Introduction
The MYC oncogene is a DNA binding protein of the basic ± helix ± loop ± helix ± leucine zipper (bHLHLZ) family whose biological function is linked to its ability to regulate expression of speci®c target genes (Dang, 1999; Grandori and Eisenman, 1997) . Deregulated expression of MYC contributes to tumorigenesis both in humans as well as in animal models (reviewed by Nesbit et al., 1999) , while studies in cultured cells have delineated a crucial role for MYC in the transition from quiescence to cell proliferation (reviewed by Eilers, 1999) .
The speci®c DNA binding activity of MYC is strictly linked to its dimerization partner MAX, a ubiquitously expressed bHLHLZ protein (Blackwood and Eisenman, 1991; Blackwood et al., 1992) . MYC-MAX complexes are part of a network of bHLHLZ proteins that, like MYC, have the ability to dimerize with MAX. Members of this network include MAD1-4 and MNT (Hurlin et al., 1996 (Hurlin et al., , 1997 . The MAD-MAX and MNT-MAX complexes appear to antagonize MYC-MAX by sharing the same DNA binding speci®city but acting as repressors instead of activators of transcription. The repressor activity of MAD and MNT proteins is due to their common property of recruiting the co-repressor Sin 3 and histone deacetylase molecules to DNA (Ayer et al., 1995; Hurlin et al., 1997; Laherty et al., 1997) . This complex presumably has the ability to alter chromatin structure at speci®c DNA regions thereby interfering with transcription (Knoep¯er and Eisenman, 1999) .
The transactivation ability of MYC maps to separate regions contained within amino acids 1 to 143, which also contains two highly conserved domains termed MYC box I (MBI; aa 45 ± 63) and MYC box II (MBII; aa 128 ± 143). Although either box alone is not sucient, together MBI and MBII and the sequence between them, confer the highest level of transactivation of any Myc N-terminal region when fused to a Ga14 DNA binding domain (Kato et al., 1990) . However, only MBII is absolutely required for MYC transforming function (Stone et al., 1987) . More recently, a novel property of MYC as a repressor through initiator DNA elements (Inr), has been de®ned. This property also maps to MYC box II and deletion of this region abolishes the ability of MYC to act as a repressor. In addition to MBII, also amino acids 92 to 106 of the MYC N-terminus have been involved in repression (Philipp et al., 1994) . These results have generated a controversy on the role of MBII because, when assayed in the context of fulllength Myc, its deletion does not aect transactivation of most reporter constructs (Li et al., 1994) . Nonetheless, a study of the Myc target gene a-prothymosin, which contains MYC binding sites distal from the promoter, indicated a requirement for MBII for transactivation (Li et al., 1994) ; (Desbarats et al., 1996) .
The proposed role of MBII in repression and the absolute requirement of MBII for MYC transforming activity, prompted the hypothesis that transcriptional repression might be sucient to mediate MYC biological function. This hypothesis found support also from the analysis of a natural occurring variant of MYC, named MYC-S (Spotts et al., 1997) . MYC-S lacks part of the transactivation domain up to amino acid 101 and mimics MYC activity both as a promoter of cell proliferation and of apoptosis in immortalized rodent cell lines (Xiao et al., 1998) . When analysed in transient assays MYC-S functions as a repressor at initiator element sequences but has no transactivating properties (Spotts et al., 1997; Xiao et al., 1998) . Nevertheless, MYC-S contains MBII, which in some contexts appears important for transactivation functions as discussed above and that recently has been linked with the ability of MBII to interact with an acetyltransferase complex (McMahon et al., 2000) . In addition, MYC-S contains 26 amino acids N-terminal to MBII that have also been also linked to MYC's ability to activate transcription (Kato et al., 1990) . It was therefore of interest to us to study the eects of MYC-S upon endogenous target gene expression and to establish how the transcriptional activation and repression properties of MYC relate to cell-cycle progression and apoptosis.
In order to analyse MYC's biological function in the absence of possible mutations that commonly occur in established cell lines, we expressed the conditional MYC-ER TM protein and mutant derivatives in mortal human ®broblasts, WI38. MYC-ER TM is encoded by a chimeric gene between full-length cmyc and a mutant estrogen receptor (ER TM ) with a deletion that abrogates the transcriptional activation properties inherent to the ER (Littlewood et al., 1995) . This system allows monitoring of immediate cell-cycle and gene expression changes as a consequence of MYC-ER TM activation by 4-hydroxytamoxifen (4-OHT) (Coller et al., 2000) .
Results

Activation of MYC-ER
TM but not MYC-S-ER TM is sufficient to promote S phase in quiescent WI38 cells
In order to study the eects of MYC in primary human ®broblasts early passage WI38 cells were infected with a retroviral vector expressing the MYC-ER TM fusion protein, selected with puromycin and grown to con¯uence with no further passages. To achieve quiescence, the medium was not changed for 7 to 8 days after plating as previously described (Cosenza et al., 1988) . Under these conditions the levels of endogenous c-myc RNA are very low (Grandori et al., 1996) . Upon addition of 4-OHT cells entered S phase starting within 15 h (Figure 1a ). This eect required the transcriptional activation domain of MYC as shown by the parallel analysis of the deletion mutant DMYC-ER TM (deletion 106 ± 143) ( Figure 1a ) and also occurred in the absence of added growth factors. Similar results were obtained with density arrested and serum-starved cultures as shown in Figure 1b . As an (Stone et al., 1987) were split once in puromycin to select transduced cells and then density-arrested. Exposure to 4-OHT was for the indicated times. The percentage of cells entering S phase was analysed by FACS after staining with propidium iodide. (b) Cells were infected, density arrested and analysed as above except that they were starved in 0.1% serum for 36 h prior induction. (c) Appearance of phosphorylated Rb and increased Cdk2 kinase activity following MYC-ER TM activation with 4-OHT in serum starved WI38 cells. Rb was detected by immunoprecipitation and then Western blotting with the same anti-Rb antiserum (Santa Cruz). Cdk-2 kinase activity was tested by immunoprecipitation with anti-Cdk2 serum (Santa Cruz) followed by in vitro histone H1 phosphorylation and analysis by SDS ± PAGE. (Rabinovitch, 1994) independent con®rmation of cell-cycle progression, the state of Rb phosphorylation and activation of cyclin dependent kinases was also monitored. These experiments demonstrated an appearance of hyperphosphorylated Rb by 8 h to 13 h after 4-OHT treatment with parallel activation of cyclin dependent kinase 2, Cdk2 (Figure 1c ). The ability of MYC to promote S phase entry of primary cells in the absence of added serum con®rms the hypothesis that MYC is a key regulator of cell-cycle progression and provides a new model to study MYC function in the absence of altered cell-cycle control mechanisms that are common in established cell lines (Quelle et al., 1995) .
We next examined the activity of a MYC variant, MYC-S, that arises from translation initiation at an internal AUG codon at position 101 of wild-type MYC and therefore preserves part of the transcriptional activation domain and MBII (Spotts et al., 1997; Xiao et al., 1998) . This mutant was recently shown to mimic wild-type MYC in its ability to regulate proliferation and apoptosis of rodent cell lines and to rescue the slow growth phenotype of rat c-myc null cells (Xiao et al., 1998) . Our ®ndings show that MYC-S-ER TM has marginal activity relative to wild-type MYC-ER TM as inducer of S phase entry ( Figure 1d ). Also, MYC-S-ER TM failed to cause apoptosis of serum starved WI38 cells as shown by propidium iodide staining of ®xed cells ( Figure 2) . Quantitation of the sub-G1 peak indicated that only 2% of cells expressing MYC-S-ER TM are apoptotic in comparison with 70% of cells expressing wild-type MYC-ER TM 48 h after 4-OHT addition. These ®ndings were also con®rmed by the absence of a DNA ladder in the MYC-S-ER TM sample ( Figure 3 ). Expression levels of MYC-S-ER TM assayed by immunoprecipitation of metabolically labeled cells indicated that this mutant protein was expressed at levels similar to the wild-type MYC-ER TM (1.8-fold lower than wild-type MYC-ER TM , Figure 4a ). However, upon few cell passages the levels of MYC-S-ER TM were similar if not more elevated than wild-type MYC-ER TM ( Figure 4b ). We also tried to compare the levels of MYC-S-ER TM to endogenous Myc in asynchronous cultures but its levels were too low to discriminate it from background bands (as indicated by asterisks in Figure 2 Analysis of apoptotic eect of MYC-ER TM and MYC-S-ER TM in WI38 cells. Serum-starved cells were exposed to 4-OHT and collected at the indicated times. Propidium iodide-stained cells were analysed by FACS and the data were quantitated by Multicycle software (Rabinovitch, 1994) . The percentage of apoptotic cells (subG1 peak) at 24 and 48 h after addition of 4-OHT were 23 and 69% for MYC-ER TM respectively, as compared to 6 and 2% for MYC-S-ER TM respectively Figure 3 Parallel samples form the experiment described in Figure 2 were analysed for the presence of a DNA nucleosomal ladder by agarose gel electrophoresis Figure 4b ). Therefore the levels of MYC-S-ER TM were compared to endogenous MYC during its peak expression after serum stimulation of WI38 cells and found that MYC-S-ER TM levels are markedly elevated (approximately * 40-fold higher, Figure 4c ). Because this estimate was derived from metabolic labeling of cells it may be also aected by the synthetic rate and thus it should be considered an approximation. Nevertheless, these data indicate that the lack of certain activities of MYC-S-ER TM relative to MYC-ER TM are unlikely due to low expression levels.
As a control of its functional integrity, MYC-S-ER TM was introduced into rat c-myc null cells where its capacity to rescue the slow growth phenotype was con®rmed, albeit at lower eciency that wild-type MYC-ER TM (Figure 4d ). In the rescued rat c-myc null cells, the expression levels of MYC-ER TM and MYC-S-ER TM is shown in Figure 4a . Here, the MYC-S-ER TM levels were twofold lower than wild-type MYC-ER TM also indicating that its lack of biological activity in WI38 cells is unlikely to be due to lower expression levels but rather re¯ects a defect in the function of MYC-S-ER TM to override cell cycle arrest in quiescent WI38 cultures. Because the assay used in the rat cell line was dierent from the one used in W138 cells, we re-analysed the function of MYC-S-ER TM as promoter of cellular proliferation in WI38 this time in the presence of serum. The results show that MYC-S-ER TM stimulates proliferation of WI38 cells better than wildtype MYC-ER TM that, after an initial burst of division, caused prominent apoptosis despite the presence of 10% fetal calf serum (Figure 4e ). We conclude that there is a functional distinction between MYC and MYC-S both in their capacity to override cellular quiescence of serum depleted cultures and to promote apoptosis when assayed in mortal cells. In addition, Myc-S retains the ability to stimulate proliferation of WI38 cells when assayed in asynchronous culture in the presence of serum.
Regulation of endogenous target genes by MYC-ER TM and MYC-S-ER TM
We next examined the potential of MYC-ER TM to regulate the transcription of previously characterized MYC target genes in density arrested WI38 cells. A time course experiment revealed that three targets (ODC, DDX18 and cdc25A) all showed increased mRNA levels starting as soon as 2 h after the addition of 4-OHT, which continued to increase up to 16 h after 4-OHT, reaching a maximum of threefold for DDX18 (previously named MrDb; Grandori et al., 1996) and (Figure 5a ). Due to the low levels of cdc25A mRNA, we could not accurately quantitate its induction levels. Also, both DDX18 and ODC mRNAs were increased by the combined addition of 4-OHT and cycloheximide relative to cycloheximide alone (*twofold for DDX18 and 4.5-fold for ODC, Figure  5b ). This is consistent with DDX18 and ODC being under the direct control of MYC. In contrast to previous observations (Galaktionov et al., 1996) , the levels of cdc25A were markedly reduced by exposure to cycloheximide (Figure 5b) , suggesting that its induction may not be a direct eect of MYC in these cells. As a control we also examined regulation of target genes by a transactivation mutant, DMYC-ER TM (deletion of amino acid 106 to 143), and found that it has only marginal activity on DDX18 and ODC transcription (Figure 5c ).
Finally, we compared the eect of MYC-S-ER TM , wild-type MYC-ER TM or empty vector (pBabe) on both transcriptional activation and repression in WI38 cells and in the c-myc7/7 rat cell line. The results shown in Figure 5d indicated that MYC-S-ER TM had no detectable eects upon transcriptional activation of DDX18 in human primary ®broblasts (Figure 5d ). However, when we assayed targets of both transcriptional activation and repression in the rescued rat cmyc null cells, we found the surprising result that MYC-S is both a weak activator as well as a weak repressor of the endogenous target genes CAD (Miltenberger et al., 1995) , GADD45 (Marhin et al., 1997) (Figure 6a ) and DDX18 (data not shown). The low levels of GADD45 mRNA before addition of 4-OHT in the KO-reconstituted cells with MYC-ER TM indicates some leakiness of the conditional protein (Figure 6a) . Also, the high levels of GADD45 mRNA observed in the parental TGR control (Figure 6a) , probably re¯ects the capacity of these cells to grow to a high cell density in contrast to the c-myc null cells.
The weak transcriptional activation and the repression properties of MYC-S-ER TM also became apparent in WI38 cells when we increased the sensitivity of our detection system by employing poly(A) + RNA for Northern analysis. As shown in Figure 6b , MYC-S-ER TM activated transcription of the ODC gene but failed to repress expression of GADD45. These results indicate that MYC-S-ER TM is a weak transcriptional activator while its repressor function in mortal cells is undetectable at least on the target gene here examined.
Discussion
MYC has been shown previously to stimulate S phase progression of immortalized ®broblasts in the absence of added growth factors (Eilers et al., 1989) . However, because cell immortalization is usually accompanied by mutations in crucial cell-cycle control genes (Quelle et al., 1995; Zindy et al., 1998) , we explored the activity of MYC in mortal ®broblasts at early passages. We show that activation of the conditional MYC-ER TM fusion protein, in the absence of added growth factors, is sucient to cause cell-cycle progression of a 
(a) Density-arrested WI38-MYC-ER
TM cells were induced with 4-OHT and RNA was extracted at the indicated times. Ten mg of RNA from each sample was analysed by Northern blotting with cDNA probes corresponding to DDX18 (Grandori et al., 1996) , ODC (Kahana and Nathans, 1984) , cdc25A (Galaktionov et al., 1996) , and GAPDH used as control for loading. (b) The induction of the above mRNAs was tested for sensitivity to cyclohexamide in otherwise identical conditions to (a). (c) Induction of MYC-target genes is dependent on the presence of transcriptionally active MYC as demonstrated by the lack of induction when cells were infected with the mutant DMYC-ER
TM as in (a). (d) WI38 cells expressing MYC-ER TM
, MYC-S-ER TM or empty vector were serum-starved and then exposed to 4-OHT for the indicated times. The Max probe is used as a loading control. No detectable induction of DDX18 is observed with MYC-S-ER TM considerable fraction of quiescent cells. We also show that cells also undergo apoptosis within 48 h of MYC-ER TM activation as previously observed for immortalized cell lines (Askew et al., 1991) (Evan et al., 1992) . These results demonstrate the potential of MYC to act as a key regulator of cell proliferation and apoptosis in mortal ®broblasts. However, in other cell types, either activation of conditional MYC or overexpression of constitutive MYC, are not sucient for cell-cycle progression. For example in B cells, MYC induces expression of certain target genes, such as, ODC or hTert, but fails to promote S phase entry in the absence of serum (Wu et al., 1999) . Also in B cells, constitutive MYC overexpression aects cell growth by increasing cell size and protein synthesis (Iritani and Eisenman, 1999; Schuhmacher et al., 1999) . Similarly, overexpression of Drosophila MYC in wing disk increases cell size but has limited eects on cell division (Johnston et al., 1999) . In this regard, we have also noticed an increase in protein synthesis that accompanied cell-cycle progression in consequence to MYC-ER TM activation and we are in the process of determining MYC eect on cell mass.
The in¯uence of the cellular background is also apparent from our analysis of the naturally occurring MYC variant MYC-S (Spotts et al., 1997) , which has been shown to mimic full-length MYC in promoting proliferation and apoptosis of immortalized cells (Xiao et al., 1998) . In WI38 cells MYC-S, reconstructed as a fusion protein, MYC-S-ER TM , failed to induce S phase progression and apoptosis in quiescent serum starved cells. However, MYC-S retained the ability to stimulate proliferation of WI38 cells in the presence of serum and, perhaps due to its lack of apoptotic response, was also much more eective then wild-type MYC in this respect. Its inability to override quiescence of mortal cells may explain the lack of MYC-S transforming function in primary rat embryo ®broblasts (Xiao et al., TM when compared to the levels reached by MYC-ER TM . In contrast, no detectable repression of GADD45 is observed. Quantitation was performed as in (a) 1998). Similarly a previously described MYC insertion mutant, Ins 105, while highly active in transformation of the established Rat 1A cells, was defective in transformation of primary rat embryo ®broblasts (Stone et al., 1987) .
MYC-S initiates at an alternative AUG codon at position 101 of wild-type MYC and therefore preserves part of the transactivation domain as well as MBII. While MYC-S was previously reported to act solely as a repressor in transient assays, we determined that MYC-S acts both as a weak activator and a weak repressor in the rescued c-myc null cell line by examining the expression levels of endogenous known MYC target genes. This transactivator property of MYC-S, albeit weak, has not been detected in transient assays but is likely to reside both in MBII and in the 26 amino acids N-terminal to it as previously mentioned (Kato et al., 1990) . This latter part includes several acidic residues within a region that was shown to be essential for transformation (Stone et al., 1987) . Also a possible molecular mechanism for MBII role in transactivation has been recently provided by the identi®cation of a new MBII interacting protein, TRRAP (McMahon et al., 2000) . TRRAP is part of a larger transcription activation complex that among other components also includes a protein with acetyltransferase activity, the mammalian homologue of the yeast GCN5 (McMahon et al., 2000) . Therefore the ability of MYC-S to activate endogenous genes might be linked to a chromatin remodeling function, a property which may not be required for transactivation of most unintegrated reporter constructs.
The lack of activity of MYC-S-ER TM to drive quiescent WI38 cells into S phase or apoptosis, correlated with low levels of activation of target genes and with a complete inability to repress the endogenous target gene GADD45 mRNA. These observations indicate that there might be a dierent threshold of MYC activity required in established cell lines versus mortal cells. In other words, a low level of activation and repression of target genes carried on by MYC-S might be sucient to elicit a proliferative and apoptotic response in immortalized cells where some of the cell-cycle control mechanisms are commonly altered (Quelle et al., 1995; Zindy et al., 1998) . On the contrary, the full transcriptional repression and activating properties of Myc are required in mortal cells both to override cellular quiescence and to elicit an apoptotic response. It is noteworthy that MYC-S-ER TM is a strong stimulator of proliferation of WI38 cells when assayed in asynchronous cultures in the presence of serum. Its activity is markedly dierent from wild-type MYC-ER TM whose sustained activation leads to progressive cell death thereby limiting the assessment of its role in long-term proliferation assays of WI38 cells.
Why does MYC-S act as a weak repressor in immortalized cell lines yet fails to repress in primary cells? One reason could be that MBII, although required, is not sucient for repression of endogenous genes in normal cells. Indeed, it has been reported that the region between amino acids 92 to 106 of MYC Nterminus, in part truncated in MYC-S, are essential for repression of the cyclin D1 promoter (Philipp et al., 1994) . Alternatively, the MYC N-terminus has been shown to interact with a number of cellular proteins including members of the Rb family, and the potential tumor suppressor, Bin1, which requires both MBI and MBII for association (for review see Sakamuro and Prendergast, 1999) . These proteins may regulate the transcriptional repressor function of MYC and their activity could be dierent in primary versus immortalized cells. In this respect although WI38 cells are mortal cells they express an alternatively spliced forms of Bin1 that relieves MYC inhibition (Wechsler-Reya et al., 1997) . This splicing event had been observed in all human cell lines examined and its appearance correlates with malignant transformation of human melanocytes (Ge et al., 1999) . Therefore the lack of functional Bin1 in WI38 cells might constitute a permissive environment for MYC function but does not explain the dierential eects of MYC versus MYC-S in these cells.
In summary we have examined the activity of wildtype MYC and its natural occurring variant MYC-S as conditional fusion proteins with a defective estrogen receptor (ER TM ) and expressed both proteins in mortal human ®broblasts. Our results indicate that an intact MYC N-terminus which enable MYC to fully activate and repress endogenous target genes is required to drive S phase of quiescent cells and to elicit an apoptotic response. Finally, we derive from MYC-S transcriptional properties that MBII might have a dual role in repression and activation but that other regions of MYC N-terminus contribute as well to these activities. In the future, speci®c mutations of MBII, shall be tested in this experimental system to test the hypothesis that MBII, dispensable for activation in transient assays, might be necessary for activation of endogenous target genes.
Material and methods
Retroviral vectors and cell culture
The pBabe-puro vectors expressing MYC-ER TM and D-MYC-ER TM were kindly provided by T Littlewood. MYC-S-ER TM was constructed by PCR of wild-type c-myc-er TM using the 5' primer CTGGGATCCGCCGCCATGGT-GACCGAGCTGCTGGG (the ATG corresponding to MYC amino acid 101 is underlined) and a 3' primer corresponding to the c-myc-er junction (Littlewood et al., 1995) . The PCR fragment was cut with BamHI and inserted in place of the wild-type c-myc BamHI fragment in the original c-myc-er TM construct. The MYC gene was then fully sequenced. To generate amphotropic retroviral vector stocks we co-transfected the described pBabe-based plasmids with a packaging defective helper plasmid pSV-PsiÐA-MLV (Muller et al., 1991) in 293T cells. Brie¯y, cells were seeded at 2610 6 /15 cm plate in Dulbecco's Modi®ed Eagle Medium (DME) with 10% fetal calf serum. The next day cells were transfected with 20 mg of vector and helper plasmids following standard protocols. Medium was changed the next day. After 48 and 72 h viral supernatants were harvested, ®ltered and either used immediately to infect WI38 cells or frozen at 7708C.
WI38 cells (ATCCcat#75-ccl) were frozen in multiple aliquots between passages 5 and 8, with passage 1 being the original ATCC culture received. Cells were thawed and split once before infection. On day 1, subcon¯uent WI38 cells were infected with 5 ml of viral supernatant in a 10 cm plate in the presence of 4 mg/ml polybrene. On day 2, infection was repeated again. On day 3 cells were split 1 : 4 or 1 : 6 in phenol-red free medium containing 10% fetal calf serum and selected in the presence of puromycin at 2.5 mg/ml. Selection was monitored by control cultures not exposed to the virus, that generally died in 2 or 3 days upon puromycin addition, while little or no cell death was detected in the infected cultures. Cells were grown to con¯uence, usually for 1 week, without further media changes. Density-arrested cultures were induced with 200 nM 4-OHT or serum-starved (0.1% fetal calf serum) for 36 ± 48 h and then induced. Where speci®ed, cycloheximide was added at 10 mg/ml 30 min prior to addition of 4-OHT.
Rat c-myc null cells were obtained from J Sedivy (Mateyak et al., 1997) , cultured in DME containing 10% calf serum and infected as described above with retroviral vectors expressing MYC-ER TM , MYC-S-ER TM , or empty vector. Puromycin-selected pools were tested for growth properties and by Northern blotting within a few passages after selection was complete. The parental c-myc wild-type cells, were infected with an empty virus, selected with puromycin and used as controls.
FACS analysis and detection of apoptosis
For cell-cycle analysis synchronized, density-arrested and serum-starved cells were induced as described above, washed in PBS and ®xed at the indicated times with 75% ethanol, stained with propidium iodide and analysed by FACS using a Calibur Instrument. For apoptosis analysis care was taken to collect all the¯oating round cells during the washes and then cells were ®xed and stained as above. Distribution of cells in subG1 (apoptotic), G1, S, G2 fractions were quantitated with the Multicycle software (Rabinovitch, 1994) . In addition, for DNA ladder analysis, DNA was extracted by standard protocols, separated on a 2% agarose gel and stained with ethidium bromide.
Protein analysis
MYC proteins expression was determined by metabolic labeling of W138 cultures followed by immunoprecipitation with an antibody against the N-terminal 262 amino acids of human MYC (Blackwood et al., 1992) . Brie¯y, cells were labeled with 35 S methionine at 200 mCi/ml for 1 h, washed in PBS and lysed in antibody buer (20 mM Tris HCI pH 7.4. 50 mM NaCl, 0.5% deoxycholate, 0.5% SDS, 1 mM EDTA). Samples were normalized for TCA-precipitable counts and immunoprecipitates were analysed by SDS ± PAGE.
Cyclin dependent kinase 2 activity was tested by lysing cells in a modi®ed RIPA buer (25 mM Tris HCl pH 7.5, 125 mM NaCl, 2.5 mM EDTA, 0.05% SDS, 0.5% deoxycholate, 0.5% NP40 and 10% glycerol). Two hundered mg of protein lysates were immunoprecipitated with anti-cdk2 antibody (Santa Cruz), washed two times in modi®ed RIPA buer and two times in kinase buer (50 mM HEPES pH 7.5, 10 mM MgCl2, 2.5 mM EGTA, 10 mM B-glycerophosphate, 0.1 mM NaV04, 1 mM NaFl, 1 mM DTT). Four mg of Histone H1 were added to each immunoprecipitate in 20 ml of kinase buer containing 10 mCi of g-32 P-ATP. Products were analysed by SDS ± PAGE and visualized by autoradiography.
Phosphorylation of the retinoblastoma protein, Rb, was analysed by Western blotting after immunoprecipitating 300 mg of protein lysates with anti-Rb (Santa Cruz) followed by Western blotting. Filters were probed with the same antibody and visualized by chemiluminescence.
Northern blotting
For total RNA analysis cells were lysed in Trizol (Sigma) and extracted following the manufacturer's instructions. Samples were separated on 1.2% formaldehyde-agarose gels, blotted to Hybond N + membranes (Amersham) and hybridized in Church and Gilbert buer at 658C. For specimens from multiple species the hybridization temperature was lowered to 588C. Poly(A) + RNA was obtained using the Qiagen extraction kit.
The following probes were used: DDX18, 1.9 kB NotI to EcoRI fragment including all the coding region (Grandori et al., 1996) ; ornithine decarboxylase (ODC), a mouse cDNA (Kahana and Nathans, 1984) ; cdc25A, a human cDNA corresponding to the entire open reading frame (Galaktionov et al., 1996) ; Max, a 0.5 Kb EcoRI of cDNA (Blackwood and Eisenman, 1991) ; GAPDH, a 1.8 Kb PstI fragment of human cDNA; GADD45, a rat cDNA probe (Marhin et al., 1997) ; CAD, a mouse cDNA (Miltenberger et al., 1995) .
